Australia: Infrastructure and Innovations for Clinical Trials

Sponsors seeking venues for pharmaceutical research and development would do well to consider Australia – offering a highly favorable, stable environment and experienced, capable local expertise. This article is the second in a three-part series: Here, we examine the landscape for clinical trials, including infrastructure, government funding support and incentives, patient centricity, patient recruitment, and the adoption of innovation.

Interested in more? Check out part 1 and part 3.

Open PDF

Return to Insights Center